Answers are grounded in this paper and cite their sources.
The results demonstrate that ATF4 is a novel metabolic effector of mTORC1 in the liver, extending the molecular consequences of feeding and insulin-induced mTORC1 signaling in this key metabolic tissue to the control of amino acid metabolism.
No takes yet. Share an insight, caveat, or question.
Byles et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: